Thrombophlebitis migrans as a footprint of Buerger's disease: a prospective-descriptive study in north-east of Iran
- PMID: 17554578
- DOI: 10.1007/s10067-007-0652-8
Thrombophlebitis migrans as a footprint of Buerger's disease: a prospective-descriptive study in north-east of Iran
Abstract
The pathogenesis of thrombophlebitis migrans is as unknown as the etiology of Buerger's disease (BD). In the past, thrombophlebitis migrans was a major criterion used in the diagnosis of BD, whereas today it is not as important as before and it is often forgotten to be asked about from patients with BD. In this project, during a 22-month prospective study on 86 patients suffering from BD, 65.4% had the history or sign of thrombophlebitis migrans, which in 25.6% of them, it was the first presentation of the disease and in 4.7% of them, it was the main cause of complaint. Thrombophlebitis migrans had initially occurred 9 years before the patient showed any sign of the disease (with the time range of a maximum of 22 years and a minimum of 4 months). In 45% of patients who had recommenced cigarette smoking, thrombophlebitis migrans occurred about 1-4 months before the new onset of their acute ischemic signs. Superficial thrombophlebitis migrans can be considered as a warning sign for BD onset in Asian young male smokers. With regard to the variety in the clinical feature and localization of appearance of thrombophlebitis migrans in the studied patients and its unknown pathogenesis, there should be more studies and researches toward understanding the nature of BD and thrombophlebitis migrans as its footprint.
Similar articles
-
[Superficial venous thrombosis as a sign indicative of Buerger's disease].Phlebologie. 1976 Apr-Jun;29(2):119-20. Phlebologie. 1976. PMID: 996104 French. No abstract available.
-
[Thrombophlebitis migrans of superficial veins during thromboangiitis obliterans].Pol Arch Med Wewn. 1958;28(5):839-40. Pol Arch Med Wewn. 1958. PMID: 13601346 Polish. No abstract available.
-
Diagnostic criteria for Buerger's disease: International Consensus of VAS - European Independent Foundation in Angiology/Vascular Medicine.Int Angiol. 2023 Oct;42(5):396-401. doi: 10.23736/S0392-9590.23.05098-8. Int Angiol. 2023. PMID: 38010012
-
Diagnostic criteria and treatment of Buerger's disease: a review.Int J Low Extrem Wounds. 2006 Jun;5(2):89-95. doi: 10.1177/1534734606288817. Int J Low Extrem Wounds. 2006. PMID: 16698911 Review.
-
Thromboangiitis obliterans. An update on Buerger's disease.West J Med. 1998 Apr;168(4):255-60. West J Med. 1998. PMID: 9584663 Free PMC article. Review.
Cited by
-
Thromboangiitis obliterans episode: autoimmune flare-up or reinfection?Vasc Health Risk Manag. 2018 Sep 28;14:247-251. doi: 10.2147/VHRM.S172047. eCollection 2018. Vasc Health Risk Manag. 2018. PMID: 30319267 Free PMC article.
-
Buerger's disease as an indicator of socioeconomic development in different societies, a cross-sectional descriptive study in the North-East of Iran.Arch Med Sci. 2010 Jun 30;6(3):343-7. doi: 10.5114/aoms.2010.14253. Arch Med Sci. 2010. PMID: 22371769 Free PMC article.
-
Buerger's disease: providing integrated care.J Multidiscip Healthc. 2016 Oct 12;9:511-518. doi: 10.2147/JMDH.S109985. eCollection 2016. J Multidiscip Healthc. 2016. PMID: 27785045 Free PMC article. Review.
-
The role of folic acid on the hyperhomocysteinemia in the Buerger's disease (Thromboangiitis Obliterans).J Res Med Sci. 2014 Nov;19(11):1034-7. J Res Med Sci. 2014. PMID: 25657746 Free PMC article.
-
Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review.Iran J Basic Med Sci. 2019 Mar;22(3):215-224. doi: 10.22038/ijbms.2019.31119.7513. Iran J Basic Med Sci. 2019. PMID: 31156780 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous